Trial intelligence / Profile preview

Injectable Collagen Scaffold + HUC-MSCs in Decompensated Cirrhosis

NCT02786017Phase 2Unknown

Sponsor
Chinese Academy of Sciences
Start
May 2016
Primary completion
Dec 2020
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in decompensated cirrhosis, sponsored by Chinese Academy of Sciences. Status: unknown.

02

Drugs

human umbilical cord derived mesenchymal stem cells
03

Conditions

decompensated cirrhosis

Beyond the preview

Go deeper on NCT02786017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02786017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call